This study is looking to understand why some people with pulmonary hypertension (high blood pressure in the arteries of the lungs) join or finish clinical trials, while others don't. It's an observational study, meaning you won't receive any new treatments. Instead, researchers will gather information about your experiences with clinical trials. They want to see what factors might make it easier or harder for different groups of people to participate. The goal is to learn how to make future clinical trials better for patients with pulmonary hypertension. They hope to enroll 500 participants. To be eligible, you must be at least 18 years old, have a confirmed diagnosis of pulmonary hypertension, and be able to understand and sign the consent form.

Study design

This is an observational study aiming to enroll 500 participants. It is not testing any specific intervention or drug.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The study will track how many patients enroll in research at 3 months and how many remain in research to completion at 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.